YearFourth Consecutive Quarter of Double-Digit Revenue GrowthFiscal YTD Operating Cash Flow up 17% Year-Over-YearSAN ...

Candidate genetic variants included in a genetic risk algorithm may not meet standards of reasonable clinical efficacy in identifying opioid use disorder risk, according to a study published in JAMA ...

Aspirion, the healthcare technology revenue cycle management ("RCM") leader for denials, payment variance, and complex claims, has been named 2025 Best in KLAS for Denials Management for the second ...

According to the authors of a recent paper, "the placebo response in clinical trials has four components: regression to the mean (RTM), measurement artefacts, natural tendency (NT) of the disease, and ...

BofA Securities made adjustments to its outlook on AMD (NASDAQ:AMD) shares, lowering the price target to $135 from the previous $155, while keeping a Neutral stance on the company. According to ...